Genomics Market By Product & Services Type (Products, Services), By Application Type (Disease Diagnostics, Drug Discovery, Personalized Medicine, Agriculture And Animal Research, Other), By End-User Type (Academic And Government Research, Hospitals & Clinics, Biopharmaceutical Companies, Clinical Research) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Industry Outlook

The global genomics market held US$ 13,122.9 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 10.4% during the forecast period from 2018 to 2026. The exploration of genomics has surpassed in the last three decades to massive advancements in the technology that allowed the researchers to sequence larger pieces of genome. Polymerase chain reaction (PCR) techniques, microarray and next-generation sequencing have made the whole genome sequencing cost effective and highly efficient. These advancements in the technology has assisted in the various fields of applied biology such as clinical genomics, discovery and development of novel drugs and personalized medicine for various chronic diseases. For instance, genomics have revolutionized point-of-care testing across various infectious diseases, cancer and congenital ailments enabling analysis of novel analytes, broad spectrum analytical performances and better turnaround time. Various biotechnology companies have ventured in the market of genomics changing the dynamics of the market. In 2003, the cost of sequencing of human genome of approximately US$ 3 billion. However, launch of highly advanced next-generation sequencing products by Illumina, Inc., have significantly decreased the cost of human genome sequencing to US$ 1,000. Thus, dramatic decrease in the cost of sequencing and growing investments in biopharmaceutical research have driven the growth of global genomics market. Projects such as Human Genome Project, Saudi Human Genome Program (SHGP), and U.K. 100,000 Genome Projects are further projected to drive the market for genomics worldwide. However, huge investment and research infrastructure required for genomics research are some of the major restraining factor for the growth of this market.

Market Synopsis

Get a sample copy for more information

"Increased Adoption of NGS to Drive the Genomics Market"

In 2017, products segment held the largest share in the global genomics market. The product segment is further segmented in instrumentation technology and consumables/reagents sub-segment. The instrumentation technology segment is projected to grow at a significant rate during the forecast period owing to high adoption of NGS platforms. Simplified workflow on NGS, significant reduction in costs of NGS instruments and reagents, and growing implementation of NGS in clinical application such as oncology, genetic studies, and reproductive health will further drive the market during the forecast period. With the advent of microarrays and microfluidics in point-of-care diagnostics and advancements in PCR and nucleic acid amplification technologies in DNA sequencing will further drive the market.

Get a sample copy for more information

"North America Dominated the Global Genomics Market"

In 2017, North America held the largest share in the global genomics market owing to huge investments on genomic research by government institutions, growing awareness regarding genetic analysis such as direct-to-consumer genetic testing, non-invasive prenatal testing and other genetic testing in the region. Moreover, growing number of budding biotechnology companies offering various genetic testing services in the region and presence of major biopharmaceutical giants in the region further make North America the most lucrative market in the global genomics market. Asia Pacific is projected to witness fastest growth during the forecast period owing to increasing genetic R&D activities, growing healthcare infrastructure focusing of genomic studies for drug discovery and disease treatment. Moreover, reducing cost of genomics services and foreign investments in the region further drive the growth of market. 

Get a sample copy for more information

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

Genomics market report furnishes quantitative analysis along with its latest market trends. The market is segmented based on product & services type, application, end-user and geography.

Market is studied in order to understand the current dynamics and future trends in the global genomics market. The study includes market size and forecast for all considered segments presented in the report for the period from 2016 to 2026, along with respective compound annual growth rate (CAGRs) for the forecast period from 2018 to 2026, considering 2017 as the base year. The key players currently engaged in genomics market include Thermo Fisher Scientific, Inc., Bio-Rad Technologies, Inc., Illumina, Inc., Danaher Corporation, BGI, Pacific Biosciences, Oxford Nanopore Technologies., Myriad Genetics, Inc., among others. The companies are engaged in launch of novel products and tools to maintain their position in the market. Mergers & acquisitions are an important growth strategy undertaken in the industry to keep a competitive edge in the market. For instance, Thermo Fisher Scientific acquired Life Technologies in 2016 to become the market leader in the genomics market.

Key questions answered in this report

• How the global genomics market will perform during the forecast period from 2018 to 2026?
• What are the latest trends in the genomics market and valuable opportunities for key players?
• Who are the leading players in the global genomics market?
• Which is the leading/and fastest region in the global genomics market?
• What are drivers and restrains governing the global genomics market?
• What are the applications of genomics and which is the currently leading application?

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Genomics Market Portraiture
2.2. Global Genomics Market, by Product & Services Type, 2017 (US$ Mn)
2.3. Global Genomics Market, by Application, 2017 (US$ Mn)
2.4. Global Genomics Market, by End-User, 2017 (US$ Mn)
2.5. Global Genomics Market, by Geography, 2017 (US$ Mn)

Chapter 3. Genomics: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.2.1. Driver 1
3.2.2. Driver 2
3.3. Challenges
3.3.1. Challenge 1
3.3.2. Challenge 2
3.4. Opportunities
3.4.1. Opportunity 1
3.4.2. Opportunity 2
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Genomics Market, by Key Players, 2017

Chapter 4. Global Genomics Market, by Product & Services Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Products
4.2.1. Instrumentation Technology
4.2.1.1. Sequencing Technology
4.2.1.2. Microarray
4.2.1.3. Polymerase Chain Reaction (PCR)
4.2.1.4. Nucleic Acid Extraction and Purification
4.2.1.5. Other Technologies
4.2.2. Consumables/Reagents
4.3. Services
4.3.1. Genomic Services
4.3.2. Sequencing Services
4.3.3. Data Analysis

Chapter 5. Global Genomics Market, by Application Type, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Disease Diagnostics
5.3. Drug Discovery
5.4. Personalized Medicine
5.5. Agriculture and Animal Research
5.6. Other Applications

Chapter 6. Global Genomics Market, by End-User Type, 2016-2026 (US$ Mn)
6.1. Overview
6.2. Academic and Government Research
6.3. Hospitals & Clinics
6.4. Biopharmaceutical Companies
6.5. Clinical Research

Chapter 7. Global Genomics Market, by Geography, 2016 – 2026 (US$ Mn)
7.1. North America Genomics Market Analysis, 2016 – 2026
7.1.1. North America Genomics Market, by Product & Services Type, 2016 - 2026 (US$ Mn)
7.1.2. North America Genomics Market, by Application, 2016 - 2026 (US$ Mn)
7.1.3. North America Genomics Market, by End-User, 2016 - 2026 (US$ Mn)
7.1.4. North America Genomics Market, by Country, 2016 – 2026 (US$ Mn)
7.1.4.1. U.S.
7.1.4.2. Canada
7.2. Europe Genomics Market Analysis, 2016 – 2026
7.2.1. Europe Genomics Market, by Product & Services Type, 2016 - 2026 (US$ Mn)
7.2.2. Europe Genomics Market, by Application, 2016 - 2026 (US$ Mn)
7.2.3. Europe Genomics Market, by End-User, 2016 - 2026 (US$ Mn)
7.2.4. Europe Genomics Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.2.4.1. U.K.
7.2.4.2. Germany
7.2.4.3. Rest of Europe
7.3. Asia Pacific Genomics Market Analysis, 2016 – 2026
7.3.1. Asia Pacific Genomics Market, by Product & Services Type, 2016 - 2026 (US$ Mn)
7.3.2. Asia Pacific Genomics Market, by Application, 2016 - 2026 (US$ Mn)
7.3.3. North America Genomics Market, by End-User, 2016 - 2026 (US$ Mn)
7.3.4. Asia Pacific Genomics Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.3.4.1. China
7.3.4.2. Japan
7.3.4.3. Rest of Asia Pacific
7.4. Latin America Genomics Market Analysis, 2016 – 2026
7.4.1. Latin America Genomics Market, by Product & Services Type, 2016 - 2026 (US$ Mn)
7.4.2. Latin America Genomics Market, by Application, 2016 - 2026 (US$ Mn)
7.4.3. North America Genomics Market, by End-User, 2016 - 2026 (US$ Mn)
7.4.4. Latin America Genomics Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.4.4.1. Brazil
7.4.4.2. Mexico
7.4.4.3. Rest of Latin America
7.5. Middle East & Africa Genomics Market, 2016 – 2026
7.5.1. Middle East & Africa Genomics Market, by Product & Services Type, 2016 - 2026 (US$ Mn)
7.5.2. Middle East & Africa Genomics Market, by Application, 2016 - 2026 (US$ Mn)
7.5.3. North America Genomics Market, by End-User, 2016 - 2026 (US$ Mn)
7.5.4. Middle East & Africa Genomics Market, by Region, 2016 – 2026 (US$ Mn)
7.5.4.1. GCC
7.5.4.2. Rest of Middle East & Africa

Chapter 8. Company Profiles
8.1. Thermo Fisher Scientific, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to Data Availability)
8.1.3. Product Portfolio
8.1.4. News Coverage
8.2. Agilent Technologies, Inc.
8.3. Bio-Rad Laboratories, Inc.
8.4. Merck KGaA
8.5. Danaher Corporation
8.6. GE Healthcare
8.7. BGI
8.8. Illumina, Inc.
8.9. Oxford Nanopore Technologies
8.10. Pacific Biosciences of California, Inc.
8.11. QIAGEN
8.12. Myriad Genetics, Inc.
8.13. Eurofins Scientific
8.14. 23nMe, Inc.

Note:

Modification in the list of company profiles or scope of the study can be incorporated on request.

FIG 1. Genomics Market: Research Methodology
FIG 2. Genomics: Market Segmentation
FIG 3. Global Genomics Market, by Products & Services Type, 2017 (US$ Mn)
FIG 4. Global Genomics Market, by Application, 2017 (US$ Mn)
FIG 5. Global Genomics Market, by End-User, 2017 (US$ Mn)
FIG 6. Global Genomics Market, by Geography, 2017 (US$ Mn)
FIG 7. Attractive Investment Proposition, by Geography, 2017
FIG 8. Competitive Analysis: Global Genomics Market, by Key Players, 2017
FIG 9. Global Sequencing Technology Market in Genomics, 2016-2026 (US$ Mn)
FIG 10. Global Microarray Market in Genomics, 2016-2026(US$ Mn)
FIG 11. Global Polymerase Chain Reaction (PCR) Market in Genomics, 2016-2026(US$ Mn)
FIG 12. Global ELISA Market in Genomics, 2016-2026(US$ Mn)
FIG 13. Global Nucleic Acid Extraction and Purification Market in Genomics, 2016-2026(US$ Mn)
FIG 14. Global Other Technologies Market in Genomics, 2016-2026(US$ Mn)
FIG 15. Global Consumables/Reagents Market in Genomics, 2016-2026(US$ Mn)
FIG 16. Global Genomic Services Market in Genomics, 2016-2026(US$ Mn)
FIG 17. Global Sequencing Services Market in Genomics, 2016-2026(US$ Mn)
FIG 18. Global Dana Analysis Market in Genomics, 2016-2026(US$ Mn)
FIG 19. Global Disease Diagnostics Market in Genomics, 2016-2026(US$ Mn)
FIG 20. Global Drug Discovery Market in Genomics, 2016-2026(US$ Mn)
FIG 21. Global Personalized Medicine Market in Genomics, 2016-2026(US$ Mn)
FIG 22. Global Agriculture and Animal Research Market in Genomics, 2016-2026(US$ Mn)
FIG 23. Global Other Applications Market in Genomics, 2016-2026(US$ Mn)
FIG 24. Global Academic and Government Research Market in Genomics, 2016-2026(US$ Mn)
FIG 25. Global Hospitals & Clinic Market in Genomics, 2016-2026(US$ Mn)
FIG 26. Global Biopharmaceutical Companies Market in Genomics, 2016-2026(US$ Mn)
FIG 27. Global Clinical Research Market in Genomics, 2016-2026(US$ Mn)
FIG 28. U.S. Genomics Market, 2016-2026 (US$ Mn)
FIG 29. Canada Genomics Market, 2016-2026 (US$ Mn)
FIG 30. U.K. Genomics Market, 2016-2026 (US$ Mn)
FIG 31. Germany Genomics Market, 2016-2026 (US$ Mn)
FIG 32. Rest of Europe Genomics Market, 2016-2026 (US$ Mn)
FIG 33. China Genomics Market, 2016-2026 (US$ Mn)
FIG 34. Japan Genomics Market, 2016-2026 (US$ Mn)
FIG 35. Rest of Asia Pacific Genomics Market, 2016-2026 (US$ Mn)
FIG 36. Brazil Genomics Market, 2016-2026 (US$ Mn)
FIG 37. Mexico Genomics Market, 2016-2026 (US$ Mn)
FIG 38. Rest of Latin America Genomics Market, 2016-2026 (US$ Mn)
FIG 39. GCC Genomics Market, 2016-2026 (US$ Mn)
FIG 40. Rest of Middle East & Africa Genomics Market, 2016-2026 (US$ Mn)

TABLE 1 Global Genomics Market Portraiture
TABLE 2 Global Genomics Market, by Component Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Genomics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 4 Global Genomics Market, by End-User, 2016 – 2026 (US$ Mn)
TABLE 5 Global Genomics Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 6 Global Products Market in Genomics, 2016-2026 (US$ Mn)
TABLE 7 Global Instrumentation Technology Market in Genomics, 2016-2026 (US$ Mn)
TABLE 8 Global Services Market in Genomics, 2016-2026 (US$ Mn)
TABLE 9 North America Genomics Market, by Component Type, 2016 – 2026 (US$ Mn)
TABLE 10 North America Genomics Market, by Application , 2016 – 2026 (US$ Mn)
TABLE 11 North America Genomics Market, by End-User, 2016 – 2026 (US$ Mn)
TABLE 12 North America Genomics Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 13 Europe Genomics Market, by Component Type, 2016 – 2026 (US$ Mn)
TABLE 14 Europe Genomics Market, by Application Type, 2016 – 2026 (US$ Mn)
TABLE 15 Europe Genomics Market, by End-User, 2016 – 2026 (US$ Mn)
TABLE 16 Europe Genomics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Asia Pacific Genomics Market, by Component Type, 2016 – 2026 (US$ Mn)
TABLE 18 Asia Pacific Genomics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 19 Asia Pacific Genomics Market, by End-User, 2016 – 2026 (US$ Mn)
TABLE 20 Asia Pacific Genomics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 21 Latin America Genomics Market, by Component Type, 2016 – 2026 (US$ Mn)
TABLE 22 Latin America Genomics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 23 Latin America Genomics Market, by End-User, 2016 – 2026 (US$ Mn)
TABLE 24 Latin America Genomics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 25 Middle East & Africa Genomics Market, by Component Type, 2016 – 2026 (US$ Mn)
TABLE 26 Middle East & Africa Genomics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 27 Middle East & Africa Genomics Market, by End-User, 2016 – 2026 (US$ Mn)
TABLE 28 Middle East & Africa Genomics Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 29 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 Agilent Technologies, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 Merck KGaA: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 Danaher Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 34 GE Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 35 BGI: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 36 Illumina, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 37 Oxford Nanopore Technologies: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 38 Pacific Biosciences of California, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 39 QIAGEN: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 40 Myriad Genetics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 41 Eurofins Scientific: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 42 23nME, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)